Spectrum of Causative Pathogens and Resistance Rates to Antibacterial Agents in Bacterial Prostatitis

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Bacterial prostatitis is a common infection requiring effective antibiotic therapy.
• Antibiotic resistance among causative pathogens poses a significant challenge to treatment efficacy.

Purpose of the Study:

• To determine the spectrum of bacterial pathogens causing prostatitis.
• To evaluate antimicrobial resistance rates in these pathogens across Southern Europe, the Middle East, and Africa.

Main Methods:

• Analysis of 1027 bacterial isolates from various patient samples (urine, prostatic secretion, seminal fluid, urethral).
• Identification of common pathogens and assessment of their resistance profiles to a range of antibiotics.

Main Results:

• Escherichia coli (32%) and Enterococcus spp. (21%) were the most frequent isolates.
• Generally low resistance (<15%) to piperacillin/tazobactam and carbapenems. Higher resistance rates observed in West Africa, with specific peaks in the Gulf area for certain antibiotics.
• Variable resistance noted for cephalosporins, fluoroquinolones, and macrolides, with specific patterns for Gram-negative, Gram-positive, and atypical pathogens.

Conclusions:

• Antibiotic resistance is a critical public health issue in prostatitis management.
• Geographical variations in resistance necessitate tailored, local treatment guidelines.
• Knowledge of local pathogen prevalence and susceptibility is essential for optimizing prostatitis therapy.